Press coverage about St Jude Medical (NYSE:STJ) has trended positive on Wednesday, Accern Sentiment Analysis reports. Accern identifies positive and negative media coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. St Jude Medical earned a coverage optimism score of 0.34 on Accern’s scale. Accern also assigned headlines about the medical technology company an impact score of 47.0421538023966 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.
The company has a current ratio of 1.93, a quick ratio of 1.31 and a debt-to-equity ratio of 1.20.
COPYRIGHT VIOLATION NOTICE: “St Jude Medical (STJ) Earns News Impact Rating of 0.34” was originally reported by Chaffey Breeze and is the property of of Chaffey Breeze. If you are accessing this piece on another website, it was illegally copied and republished in violation of international copyright & trademark laws. The original version of this piece can be accessed at https://www.chaffeybreeze.com/2018/02/14/st-jude-medical-stj-earns-news-impact-rating-of-0-34.html.
St Jude Medical Company Profile
St. Jude Medical, Inc is focused on the development, manufacture and distribution of cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas, and interventional pain therapy and neurostimulation devices for the management of chronic pain and movement disorders.
Receive News & Ratings for St Jude Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for St Jude Medical and related companies with MarketBeat.com's FREE daily email newsletter.